Evolent Health (EVH) Gross Margin (2015 - 2026)

Evolent Health's Gross Margin history runs 12 years deep, the most recent figure standing at 16.88% for Q1 2026.

• In Q1 2026, Gross Margin fell 431.0% year-over-year to 16.88%; the TTM figure through Mar 2026 stood at 20.18% (up 493.0% YoY), while the FY2025 annual figure was 21.31%, up 693.0% from the prior year.
• Gross Margin was 16.88% for Q1 2026 at Evolent Health, down from 20.75% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 27.41% in Q1 2023 to a low of 11.71% in Q4 2024.
• Historically, Gross Margin has averaged 20.52% across 5 years, with a median of 21.19% in 2025.
• The sharpest annual moves came in 2022 and 2025: Gross Margin slumped 1205 bps in 2022, then surged 904 bps in 2025.
• A 5-year view of Gross Margin shows it stood at 21.72% in 2022, then slipped by 16 bps to 18.28% in 2023, then slumped by 36 bps to 11.71% in 2024, then soared by 77 bps to 20.75% in 2025, then retreated by 19 bps to 16.88% in 2026.
• The last three Gross Margin figures came in at 16.88% (Q1 2026), 20.75% (Q4 2025), and 20.81% (Q3 2025), per Business Quant data.